 |
Articles: Pharmacoeconomics |
Prior Articles
Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group
PharmacoEconomics, 08/04/09
Pharmacoeconomic Considerations in Treating Actinic Keratosis
PharmacoEconomics, 08/03/09 Intramuscular Haloperidol versus Intramuscular Olanzapine for Treatment of Acute Agitation: A Cost-Minimization Study
Pharmacotherapy, 07/31/09 Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders
Journal of Substance Abuse Treatment, 07/30/09 Economic analysis of alvimopan in North American Phase III efficacy trials
American Journal of Health-System Pharmacy, 07/28/09 Trends in the Management of Type 2 Diabetes and its Prescription Drug Costs in Greece
Experimental and Clinical Endocrinology & Diabetes, 07/23/09 Denosumab in Osteoporosis and Oncology
Annals of Pharmacotherapy, 07/22/09 Cost-Effectiveness Analysis of Intracameral Cefuroxime Use for Prophylaxis of Endophthalmitis after Cataract Surgery
Ophthalmology, 07/21/09 Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada
Current Medical Research and Opinion, 07/17/09 The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa
Annals of Pharmacotherapy, 07/16/09 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method
PharmacoEconomics, 07/15/09 Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US
Current Medical Research and Opinion, 07/15/09 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
PharmacoEconomics, 07/15/09 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A
PharmacoEconomics, 07/14/09 Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
Alimentary Pharmacology and Therapeutics, 07/14/09 Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
Diabetes, Obesity and Metabolism, 07/14/09 Pharmacoeconomics of Sedation in the ICU
Critical Care Clinics, 07/13/09 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations
PharmacoEconomics, 07/13/09 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature
PharmacoEconomics, 07/10/09 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
PharmacoEconomics, 07/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
151 Available Pages
|
|
